...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

,,yeaa,,,,,,but tada ,,remember,,we are at arms length from our investment,,,,this management team controls all,,,,,,and what exactly we would get out of any deal,,,,,,,and I will surmise the majority interest will not be overly generous.....we will be the last payees on any list. Watch and see how much disresect this company will pay to the retailers!!!,,I hold little promise of any windfall for us.

Share
New Message
Please login to post a reply